Laurus Labs Limited (LAURUSLABS)

589.75

INR
+6.30(+1.08%)
As of December 6, 2024 10:00:00 AM

Laurus Labs Limited Share Price Information

24 hour Low and High

Low: 582.7
High: 591.65

All time High

700.83

Price Change 1h

+₹6.30 +1.08%

Price Change 1d

+₹6.30 +1.08%

Price Change 1w

+₹103.75 +21.35%

Laurus Labs Limited Market Information

Exchange

NSE

Market Cap

26165.38 Cr

About Laurus Labs Limited Share

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

6007

CEO

Dr. Satyanarayana Chava M.Sc., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Laurus Labs, PNB Housing shares rallied up to 11% today; here are target prices
  • Laurus Labs Limited (NSE:LAURUSLABS) most popular amongst retail investors who own 34% of the shares, institutions hold 33%
  • Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Laurus Labs, Piramal Pharma, Syngene hit 52-week high after the US House passes Biosecure Act; here is why
  • Laurus Labs Limited (NSE:LAURUSLABS) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

FAQs

Laurus Labs Limited (LAURUSLABS)

589.75

INR
+6.30(+1.08%)
As of December 6, 2024 10:00:00 AM

Laurus Labs Limited Share Price Information

24 hour Low and High

Low: 582.7
High: 591.65

All time High

700.83

Price Change 1h

+₹6.30 +1.08%

Price Change 1d

+₹6.30 +1.08%

Price Change 1w

+₹103.75 +21.35%

Laurus Labs Limited Market Information

Exchange

NSE

Market Cap

26165.38 Cr

About Laurus Labs Limited Share

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

6007

CEO

Dr. Satyanarayana Chava M.Sc., Ph.D.

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Laurus Labs, PNB Housing shares rallied up to 11% today; here are target prices
  • Laurus Labs Limited (NSE:LAURUSLABS) most popular amongst retail investors who own 34% of the shares, institutions hold 33%
  • Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • Laurus Labs, Piramal Pharma, Syngene hit 52-week high after the US House passes Biosecure Act; here is why
  • Laurus Labs Limited (NSE:LAURUSLABS) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

FAQs